Neuprozyme Therapeutics Competitors and Similar CompaniesClear all

Neuprozyme Therapeutics's competitors and similar companies include Pulmotect, CalciMedica, Bath ASU and Kamada Pharmaceuticals.

	Neuprozyme Therapeutics Neuprozyme Therapeutics is a company developing therapies for respiratory diseases.	Pulmotect Pulmotect is a biopharmaceutical company providing products for patients at risk of respiratory diseases.	CalciMedica CalciMedica (formerly known as Graybug Vision) is a biotechnology company that develops calcium release-activated calcium (CRAC) channel inhibitors.	Bath ASU Bath ASU (also known as Qualasept) is a pharmaceutical specials manufacturer.	Kamada Pharmaceuticals Kamada Pharmaceuticals is a company that develops plasma-derived protein therapeutics for orphan indications.
Founding Date	Founding Date 2018	Founding Date 2007	Founding Date 2007	Founding Date 2006	Founding Date 1990
Type	Type Private	Type Private	Type Public	Type Private	Type Public
Tags	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy	Tags Healthcare biotech drug development pharma therapy
Locations	Locations Hørsholm, DK HQ	Locations Houston, US HQ	Locations La Jolla, US HQ	Locations Corsham, GB HQ	Locations Rehovot, IL HQ Beit Kama, IL
Employees	Employees N/A	Employees 10	Employees 1614% increase	Employees 903% decrease	Employees 420
Valuation ($)	Valuation ($) N/A	Valuation ($) N/A	Valuation ($) 42.4 m	Valuation ($) N/A	Valuation ($) 317 m
Financial
Net income	Net income N/A	Net income N/A	Net income ($29.6m) (FY, 2025)	Net income N/A	Net income $20.2m (FY, 2025)
Funding
Total funding raised	Total funding raised N/A	Total funding raised $ 11.9m	Total funding raised $ 74.5m	Total funding raised N/A	Total funding raised $ 90m